Examining a stock’s 52-week price history, encompassing its low and high prices, can reveal much about its existing condition and potential future trajectory. Pacific Biosciences of California Inc’s current trading price is -79.07% away from its 52-week high, while its distance from the 52-week low is 71.55%. The stock’s price range over this period has fluctuated between $1.16 and $9.51. The company, operating within the financial sector, had a trading volume of approximately 9.58 million for the day, which was noticeably higher than the average daily share volume of 9.52 million over the last 3 months.
Pacific Biosciences of California Inc experienced a rather shaky stock market performance. The highest value in the past year was recorded at $9.51 on 01/08/24 and the lowest value was $1.16 on 07/02/24.
Exploring Financial Performance and Market Capitalization: A Comprehensive Analysis
Pacific Biosciences of California Inc (PACB) has experienced a quarterly rise of 15.70% in its revenues when compared to the same period in the previous year. Presently, the company has a total market capitalization of 602.52M and boasts a workforce of 796 employees.
Analyzing Trading Volume and Moving Average Trends
Based on Barchart.com data, the company’s moving average over the 100-day period was 1.8417, with a change in price of +0.5000. Similarly, Pacific Biosciences of California Inc recorded 8,961,920 in trading volume during the last 100 days, posting a change of +33.56%.
Understanding Ticker ‘s Debt-to-Equity Ratio: An Analysis
The debt-to-equity (D/E) ratio serves as an important indicator of a company’s financial stability and market position. By dividing a company’s total liabilities by its shareholders’ equity, the D/E ratio reveals the degree to which a company relies on debt to finance assets compared to its shareholders’ equity. At the time of writing, the total D/E ratio for PACB stands at 2.03. Similarly, the long-term debt-to-equity ratio is also 2.01.
PACB Stock Stochastic Average
Today’s raw stochastic average for Pacific Biosciences of California Inc over the last 50 days is 40.65%.This indicates a increase from the raw stochastic average of the past 20 days, which was 35.62%. Moreover, the company’s Stochastic %K and %D values for the last 20 days were 26.94% and 19.63%, respectively.
PACB Stock Price Performance Analysis
Investors’ outlook regarding the stock price performance over the year has been split, with some feeling optimistic and others feeling pessimistic, as it’s been a mixed bag. The index has shown a price gain of 8.74% this year. Over the last six months, there has been a weaker performance of 48.51%. The price of PACB leaped by -4.33% during the last 30 days period. For the last 5-days stocks have improved 6.99%.
